Physician profile
Jorge Pena
NPI 1881799658
$797.54
in general payments reported to CMS, 2019-2025
15 companies · $42.69 in 2025
The $42.69 reported for 2025 was less than what a typical Obstetrics provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $112 · 2020: $168 · 2021: $118 · 2022: $296 · 2023: $62.02 · 2025: $42.69.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $85.44 · Education: $19.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $85.44 |
| Education | $19.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $227.82 | 2019-2023 | |
| Therapeuticsmd, INC. | $141.42 | 2019-2022 | |
| Abbvie INC. | $89.53 | 2019-2022 | |
| Daiichi Sankyo INC. | $65.07 | 2022-2023 | Injectafer |
| 180 Medical, INC. | $55.23 | 2022 | |
| Ethicon US, LLC | $42.69 | 2025 | Enseal |
| Urovant Sciences INC | $27.69 | 2022 | |
| Alydia Health | $24.50 | 2021 | |
| Boston Scientific Corporation | $19.07 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $19.03 | 2022 | |
| Minerva Surgical, INC | $18.71 | 2020 | |
| Myovant Sciences INC. | $18.67 | 2021 | |
| Merck Sharp & Dohme LLC | $16.54 | 2019 | |
| Amag Pharmaceuticals, INC. | $16.03 | 2019 | |
| Coopersurgical, INC. | $15.54 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jorge Pena listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.